BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 18400078)

  • 1. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
    Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
    HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
    AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease.
    Tan DB; Lim A; Yong YK; Ponnampalavanar S; Omar S; Kamarulzaman A; French MA; Price P
    AIDS; 2011 Jul; 25(12):1455-60. PubMed ID: 21610488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterial antibody levels and immune restoration disease in HIV patients treated in South East Asia.
    Sumatoh HR; Oliver BG; Kumar M; Elliott JH; Vonthanak S; Vun MC; Singh S; Agarwal U; Kumar A; Tan HY; Kamarulzaman A; Yunihastuti E; Saraswati H; Price P
    Biomark Med; 2011 Dec; 5(6):847-53. PubMed ID: 22103621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy.
    Elliott JH; Vohith K; Saramony S; Savuth C; Dara C; Sarim C; Huffam S; Oelrichs R; Sophea P; Saphonn V; Kaldor J; Cooper DA; Chhi Vun M; French MA
    J Infect Dis; 2009 Dec; 200(11):1736-45. PubMed ID: 19874177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
    Skiest DJ; Hester LJ; Hardy RD
    J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.
    Bourgarit A; Carcelain G; Martinez V; Lascoux C; Delcey V; Gicquel B; Vicaut E; Lagrange PH; Sereni D; Autran B
    AIDS; 2006 Jan; 20(2):F1-7. PubMed ID: 16511406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
    Killian MS; Fujimura SH; Hecht FM; Levy JA
    AIDS; 2006 Jun; 20(9):1247-52. PubMed ID: 16816552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
    Tamarit A; Alberola J; Mir A; Benet I; Mira JV; Muñoz C; Galindo MJ; Navarro D
    J Clin Virol; 2004 Apr; 29(4):308-14. PubMed ID: 15018860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
    Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA;
    Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells.
    Bourgarit A; Carcelain G; Samri A; Parizot C; Lafaurie M; Abgrall S; Delcey V; Vicaut E; Sereni D; Autran B;
    J Immunol; 2009 Sep; 183(6):3915-23. PubMed ID: 19726768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.
    de Boer MG; Kroon FP; Kauffmann RH; Vriesendorp R; Zwinderman K; van Dissel JT
    Neth J Med; 2003 Dec; 61(12):408-12. PubMed ID: 15025416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
    Wadhwa A; Kaur R; Bhalla P
    Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda.
    Liechty CA; Solberg P; Were W; Ekwaru JP; Ransom RL; Weidle PJ; Downing R; Coutinho A; Mermin J
    Trop Med Int Health; 2007 Aug; 12(8):929-35. PubMed ID: 17697087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust interferon-α and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ART.
    Tan DB; Yong YK; Lim A; Tan HY; Kamarulzaman A; French M; Price P
    Clin Immunol; 2011 May; 139(2):115-21. PubMed ID: 21429806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.